Teresa Caballero‐Velázquez

Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting

Luís I. Sánchez-Abarca, Silvia Gutierrez-Cosío, Carlos Santamaría et al. · Blood · 2009 · 224 citations · Full text

Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host Disease

Fermín Sánchez‐Guijo, Teresa Caballero‐Velázquez, Olga López‐Villar et al. · Biology of Blood and Marrow Transplantation · 2014 · 117 citations · Full text

3-Year Clinical Follow-Up of the RIBS IV Clinical Trial

Fernándo Alfonso, Marı́a José Pérez-Vizcayno, Javier Cuesta et al. · JACC: Cardiovascular Interventions · 2018 · 109 citations · Full text

Rib Fracture Management, Clinical Evidence, Clinical Trials +5

Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma

Bruno Paiva, Mauricio Chandía, María‐Belén Vídriales et al. · Blood · 2014 · 93 citations

Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population

Belén Blanco, Josè Antonio Pérez-Simón, Luís I. Sánchez-Abarca et al. · Haematologica · 2009 · 57 citations · Full text